Trial Profile
A medium and long-term efficacy study of nabiximols in real life Italian setting for the treatment of spasticity in patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 21 Apr 2016 Results accessing the pharmacogenomics and pharmacodynamics of Nabiximols (Sativex) presented at the 68th Annual Meeting of the American Academy of Neurology
- 18 Feb 2016 New trial record